JP2008503523A5 - - Google Patents

Download PDF

Info

Publication number
JP2008503523A5
JP2008503523A5 JP2007517174A JP2007517174A JP2008503523A5 JP 2008503523 A5 JP2008503523 A5 JP 2008503523A5 JP 2007517174 A JP2007517174 A JP 2007517174A JP 2007517174 A JP2007517174 A JP 2007517174A JP 2008503523 A5 JP2008503523 A5 JP 2008503523A5
Authority
JP
Japan
Prior art keywords
pyridin
corresponding hydrochloride
dimethylaminomethyl
amine
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007517174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503523A (ja
JP4918486B2 (ja
Filing date
Publication date
Priority claimed from DE102004030099A external-priority patent/DE102004030099A1/de
Application filed filed Critical
Publication of JP2008503523A publication Critical patent/JP2008503523A/ja
Publication of JP2008503523A5 publication Critical patent/JP2008503523A5/ja
Application granted granted Critical
Publication of JP4918486B2 publication Critical patent/JP4918486B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007517174A 2004-06-22 2005-06-20 苦痛、うつ病及び(又は)不安障害の治療に使用するための飽和及び不飽和3−ピリジル−ベンゾシクロアルキルメチル−アミン類 Expired - Fee Related JP4918486B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004030099A DE102004030099A1 (de) 2004-06-22 2004-06-22 Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren
DE102004030099.2 2004-06-22
PCT/EP2005/006624 WO2005123681A1 (de) 2004-06-22 2005-06-20 Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen

Publications (3)

Publication Number Publication Date
JP2008503523A JP2008503523A (ja) 2008-02-07
JP2008503523A5 true JP2008503523A5 (enExample) 2011-12-22
JP4918486B2 JP4918486B2 (ja) 2012-04-18

Family

ID=35106829

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007517174A Expired - Fee Related JP4918486B2 (ja) 2004-06-22 2005-06-20 苦痛、うつ病及び(又は)不安障害の治療に使用するための飽和及び不飽和3−ピリジル−ベンゾシクロアルキルメチル−アミン類

Country Status (13)

Country Link
US (1) US8278338B2 (enExample)
EP (1) EP1758860B1 (enExample)
JP (1) JP4918486B2 (enExample)
AT (1) ATE441632T1 (enExample)
CA (1) CA2568897C (enExample)
CY (1) CY1109519T1 (enExample)
DE (2) DE102004030099A1 (enExample)
DK (1) DK1758860T3 (enExample)
ES (1) ES2333976T3 (enExample)
PL (1) PL1758860T3 (enExample)
PT (1) PT1758860E (enExample)
SI (1) SI1758860T1 (enExample)
WO (1) WO2005123681A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
MX2007012882A (es) 2005-04-22 2007-12-10 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento o prevencion de la depresion.
US8053603B2 (en) * 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
MX2010010773A (es) 2008-04-01 2011-04-11 Abbott Gmbh & Co Kg Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia.
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8853196B2 (en) 2011-08-05 2014-10-07 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2014006004A (es) 2011-11-18 2015-04-16 Abbvie Deutschland Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9643947B2 (en) 2013-08-28 2017-05-09 Northwestern University 7-membered fused heterocycles and methods of their synthesis
EP3057960B1 (en) 2013-10-17 2019-02-27 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004934A (es) 2013-10-17 2016-12-20 Abbvie Deutschland Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
CN104844471B (zh) * 2015-04-21 2017-05-03 苏州远智医药科技有限公司 一种作为dor受体拮抗剂的化合物
CN109896991B (zh) * 2017-12-08 2020-11-20 苏州远智医药科技有限公司 一种δ阿片受体拮抗剂及其用途和药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444176A (en) * 1967-04-28 1969-05-13 Mcneilab Inc Certain 4-diloweralkylamino-lower alkyl - 5 - pyridyl (or phenyl)-2,3-dihydro - 1 - benzothiepins and derivatives thereof
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
WO1992009577A1 (en) * 1990-11-22 1992-06-11 Janssen Pharmaceutica N.V. Isonicotinic acid derivatives and related spiro compounds with herbicidal action
US5668141A (en) * 1996-04-02 1997-09-16 Abbott Laboratories Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
WO1999058490A2 (en) * 1998-05-08 1999-11-18 Akzo Nobel N.V. Novel aryl-hydro naphthalenal kanamines
TW555757B (en) * 1998-07-31 2003-10-01 Akzo Nobel Nv Aminomethylcarboxylic acid derivatives
CO5271697A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
EP2258694A1 (en) * 2001-03-16 2010-12-08 Abbott Laboratories Amines as histamine-3 receptor ligands and their therapeutic applications
US7208495B2 (en) * 2001-07-05 2007-04-24 Takeda Pharmaceutical Company Limited Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
JP2004149429A (ja) * 2002-10-29 2004-05-27 Takeda Chem Ind Ltd インドール化合物およびその用途

Similar Documents

Publication Publication Date Title
JP2008503523A5 (enExample)
CN1060775C (zh) 用作神经递质重摄取抑制剂的稠合莨菪烷衍生物
JP2010539120A5 (enExample)
JP4918486B2 (ja) 苦痛、うつ病及び(又は)不安障害の治療に使用するための飽和及び不飽和3−ピリジル−ベンゾシクロアルキルメチル−アミン類
CN111712247B (zh) sGC刺激剂
JP2010539119A5 (enExample)
MX2012007409A (es) Derivados de benzamida sustituidos.
JP2010539121A5 (enExample)
TW200738645A (en) Use of 4-imidazole derivatives for CNS disorders
JP2004534816A5 (enExample)
JP2011517443A5 (enExample)
JP2002508364A (ja) セロトニン1a受容体に対して活性を有するアリールピペラジン
JP2005508872A5 (enExample)
JP2016023188A (ja) 神経突起伸長の促進におけるナノ金属の使用および神経障害の処置および/または予防
JP2017512211A (ja) アミノカルボニルカルバメート化合物
JP2005517036A5 (enExample)
CN101088498B (zh) 补骨脂酚类化合物的应用
MX2010009643A (es) Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a).
JP5600253B2 (ja) 情動障害の治療のための[2−(6−フルオロ−1h−インドール−3−イルスルファニル)ベンジル]メチルアミン
RU2565766C1 (ru) 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
CN1284056A (zh) 抗惊厥和中枢神经系统活性的双(氟苯基)烷基酰胺
JP2012512251A5 (enExample)
CN1809359A (zh) 用于治疗抑郁症和/或焦虑症的包含帕罗西汀和2-(s) -(4-氟-2-甲基-苯基)-哌嗪-1-羧酸[1-(r) -(3, 5-二-三氟-2-甲基-苯基) -乙基]甲基酰胺的联合药物
CA2405025A1 (en) (2-aminoethyl) oxime derivatives for the treatment of depression
TW201124139A (en) Solid forms of 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl}-n, n-diethylbenzamide, compositions thereof, and uses therewith